The use of erythropoietin in patients undergoing radical prostatectomy: effects on hematocrit, transfusion rates and quality of life.

@article{Gaston2006TheUO,
  title={The use of erythropoietin in patients undergoing radical prostatectomy: effects on hematocrit, transfusion rates and quality of life.},
  author={Kris E. Gaston and Erik J. Kouba and Dominic T. Moore and Raj Som Pruthi},
  journal={Urologia internationalis},
  year={2006},
  volume={77 3},
  pages={211-5}
}
OBJECTIVE It was the aim of this study to prospectively study the effects on hematocrit levels, transfusion rates and quality of life (QOL) indices in men preoperatively supplemented with recombinant erythropoietin (rEPO) undergoing radical prostatectomy for clinically localized prostate cancer. METHODS Thirty men undergoing radical prostatectomy were… CONTINUE READING